SCHEMBL4063222

SCHEMBL4063222

C=CCOc1ccccc1C(=O)c1ccccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 2/20 0.61
CYP3A4 P08684 2/20 0.47
KDM4E B2RXH2 3/20 0.47
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
TSHR P16473 3/20 0.46
GAA P10253 3/20 0.46
HPGD P15428 4/20 0.45
HSD17B10 Q99714 3/20 0.45
MAPK1 P28482 2/20 0.45
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
CYP1A2 P05177 1/20 0.42
PGR P06401 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
AR P10275 1/20 0.42
CHRM1 P11229 1/20 0.42
ALOX15 P16050 1/20 0.42
TBXA2R P21731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696302 0.92 LIG1 (0.71) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL132849 0.83 LIG1 (0.63) LIG1CYP3A4KDM4EADRB2ADRB1
1-Hydroxy-2-Allyloxybenzene SCHEMBL1562951 0.81 GAA (0.59) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL29519569 0.80 LIG1 (0.69) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL40310 0.80 LIG1 (0.69) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL3996860 0.79 STS (0.55) LIG1CYP3A4KDM4EHPGDHSD17B10
SCHEMBL22215906 0.79 LIG1 (0.58) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL6656828 0.79 LIG1 (0.58) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL3798396 0.79 KDM4E (0.71) LIG1CYP3A4KDM4EADRB2ADRB1
SCHEMBL1889645 0.79 LIG1 (0.67) LIG1CYP3A4KDM4EADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046883-B1 IMPROVED PROCESSING CONDITIONS OF POLYETHYLENE ARTICLES IN COURSE OF THEIR MANUFACTURE BY MELT PROCESSING CLARIANT FINANCE BVI LTD (VG) 2009-12-09 EP disclosed
US-20090186987-A1 Processing Conditions Of Polyethylene Articles In Course Of Their Manufacture By Melt Processing CLARIANT FINANCE (BVI) LIMITED (VG) 2009-07-23 US disclosed
US-20090186987-A1 Processing Conditions Of Polyethylene Articles In Course Of Their Manufacture By Melt Processing CLARIANT FINANCE (BVI) LIMITED (VG) 2009-07-23 US disclosed
US-20090186987-A1 Processing Conditions Of Polyethylene Articles In Course Of Their Manufacture By Melt Processing CLARIANT FINANCE (BVI) LIMITED (VG) 2009-07-23 US disclosed
EP-2046883-A1 IMPROVED PROCESSING CONDITIONS OF POLYETHYLENE ARTICLES IN COURSE OF THEIR MANUFACTURE BY MELT PROCESSING Clariant International Ltd. (CH) 2009-04-15 EP disclosed
WO-2008012319-A1 IMPROVED PROCESSING CONDITIONS OF POLYETHYLENE ARTICLES IN COURSE OF THEIR MANUFACTURE BY MELT PROCESSING CLARIANT INTERNATIONAL LTD (CH) 2008-01-31 WO disclosed
WO-2008012319-A1 IMPROVED PROCESSING CONDITIONS OF POLYETHYLENE ARTICLES IN COURSE OF THEIR MANUFACTURE BY MELT PROCESSING CLARIANT INTERNATIONAL LTD (CH) 2008-01-31 WO disclosed
US-7074853-B2 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION (US) 2006-07-11 US disclosed
US-6861458-B2 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION (US) 2005-03-01 US disclosed
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2005-01-20 US disclosed
US-6803395-B2 POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY XEROX CORPORATION 2004-10-12 US disclosed
US-20030137570-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-24 US disclosed
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes XEROX CORPORATION 2003-07-17 US disclosed
US-6569511-B1 Polysiloxane having a hydrophilic moiety and a lightfastness moiety; ink jet coating XEROX CORPORATION 2003-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014951-A1 Photoprotective and lightfastness-enhancing siloxanes LRRFIP1, LRRC59, MMS19 LIG1 66/4885CYP3A4 2957/4885KDM4E 1625/4885
US-20030133886-A1 Photoprotective and lightfastness-enhancing siloxanes ITGA1, ITGB1, ITGB8 LIG1 245/4885CYP3A4 2434/4885KDM4E 1482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.